Roberta Lorenzon
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Interferon-stimulated gene signature predicts clinical response to low-dose IL-2 in immune-mediated inflammatory diseases.
Journal: Annals of the rheumatic diseases
Published: April 24, 2026
An immunometabolic signature of major depressive disorder in systemic lupus erythematosus.
Journal: Annals of the rheumatic diseases
Published: December 10, 2025
Immunologic Profiling Suggests an Association Between Treg Cell Dysfunction and Pain in Knee Osteoarthritis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: January 25, 2025
Immunological Profiling suggests an Association between Treg dysfunction and Pain in Knee Osteoarthritis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: January 25, 2025
IL-1β signaling modulates T follicular helper and regulatory cells in human lymphoid tissues.
Journal: JCI insight
Published: October 31, 2024
Low-dose IL-2 in birch pollen allergy: A phase-2 randomized double-blind placebo-controlled trial.
Journal: The Journal of allergy and clinical immunology
Published: July 26, 2024
Low-dose interleukin-2 in patients with bipolar depression: A phase 2 randomised double-blind placebo-controlled trial.
Journal: Brain, behavior, and immunity
Published: July 23, 2024
Clinical correlates of lifetime and current comorbidity patterns in autoimmune and inflammatory diseases.
Journal: Journal of autoimmunity
Published: February 23, 2024
The universal effects of low-dose interleukin-2 across 13 autoimmune diseases in a basket clinical trial.
Journal: Journal of autoimmunity
Published: November 06, 2023
Deep immunophenotyping reveals that autoimmune and autoinflammatory disorders are spread along two immunological axes capturing disease inflammation levels and types.
Journal: Annals of the rheumatic diseases
Published: October 21, 2023
Induction of regulatory T cells and efficacy of low-dose interleukin-2 in systemic sclerosis: interventional open-label phase 1-phase 2a study.
Journal: RMD open
Published: July 16, 2023
Response to: 'Regulatory T cell frequencies in patients with rheumatoid arthritis are increased by conventional and biological DMARDs but not by JAK inhibitors' by Meyer et al.
Journal: Annals of the rheumatic diseases
Published: January 06, 2020
Last Updated: 09/26/2026